AxoGen Inc AXGN:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/20/22 EDT
9.99quote price arrow down-0.01 (-0.10%)
Volume
1,633
Close
10.00quote price arrow up+0.48 (+5.04%)
Volume
292,767
52 week range
6.87 - 22.82
Loading...
  • Open9.68
  • Day High10.06
  • Day Low9.48
  • Prev Close9.52
  • 52 Week High22.82
  • 52 Week High Date06/25/21
  • 52 Week Low6.87
  • 52 Week Low Date04/18/22

Key Stats

  • Market Cap419.80M
  • Shares Out41.98M
  • 10 Day Average Volume0.41M
  • Dividend-
  • Dividend Yield-
  • Beta0.58
  • YTD % Change6.72

KEY STATS

  • Open9.68
  • Day High10.06
  • Day Low9.48
  • Prev Close9.52
  • 52 Week High22.82
  • 52 Week High Date06/25/21
  • 52 Week Low6.87
  • 52 Week Low Date04/18/22
  • Market Cap419.80M
  • Shares Out41.98M
  • 10 Day Average Volume0.41M
  • Dividend-
  • Dividend Yield-
  • Beta0.58
  • YTD % Change6.72

RATIOS/PROFITABILITY

  • EPS (TTM)-0.77
  • P/E (TTM)-13.05
  • Fwd P/E (NTM)-20.88
  • EBITDA (TTM)-27.626M
  • ROE (TTM)-28.45%
  • Revenue (TTM)127.33M
  • Gross Margin (TTM)79.54%
  • Net Margin (TTM)-24.97%
  • Debt To Equity (MRQ)43.38%

EVENTS

  • Earnings Date08/02/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On AxoGen Inc

There is no recent news for this security.

Profile

MORE
Axogen, Inc. is focused specifically on the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. Its platform for peripheral nerve repair features a comprehensive portfolio of products, including Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, Avive Soft Tissue Membrane and Axotouch Two-Point Discriminator. Its products are used by surgeons during surgical interventions to repair...
Karen Zaderej
Chairman of the Board, President, Chief Executive Officer
Peter Mariani CPA
Chief Financial Officer, Executive Vice President
Erick Devinney
Vice President - Peripheral Nerve Science and Clinical Innovations
Mark Friedman Ph.D.
Vice President - Regulatory Affairs and Policy
Address
13631 Progress Blvd Ste 400
Alachua, FL
32615-9409
United States